Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
Heskamp, Sandra, Boerman, Otto C., Molkenboer-Kuenen, Janneke D.M., Oyen, Wim J.G., van der Graaf, Winette T.A., van Laarhoven, Hanneke W.M.Volume:
133
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.28046
Date:
July, 2013
File:
PDF, 1.32 MB
english, 2013